Clinical Trial Update: A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study of armed, activated T-cells for advanced pancreatic cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Armed, Activated T-Cells (trial product)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer, Advanced Pancreatic Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING